← Back to all trials
Completed
NCT07378865
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
Conditions: Pain
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 13
Sponsor: Vertex Pharmaceuticals Incorporated
Location: ICON - Utah - Salt Lake City Office Salt Lake City Utah
Summary
The purpose of the study is to evaluate the pharmacokinetics (PK) of suzetrigine (SUZ) and its active metabolite in breast milk of lactating female participants. In addition, the purpose is also to evaluate the relative infant dose (RID), safety and tolerability of SUZ and its active metabolite in lactating female participants.
Eligibility Criteria
Key Inclusion Criteria:
* Body mass index of greater than or equal to (≥) 18.0 to less than (\
Source: ClinicalTrials.gov (NCT07378865). StuddyBuddy aggregates publicly available trial information.
